Order Article Reprints

Yao C-C, Wang J-H, Chen C-H, Hung C-H, Yen Y-H, Kee K-M, Hu T-H, Tsai M-C, Kuo Y-H, Lu S-N. Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Diagnostics. 2023; 13(4):696. https://doi.org/10.3390/diagnostics13040696

Yao, Chih-Chien, Jing-Houng Wang, Chien-Hung Chen, Chao-Hung Hung, Yi-Hao Yen, Kwong-Ming Kee, Tsung-Hui Hu, Ming-Chao Tsai, Yuan-Hung Kuo, and Sheng-Nan Lu. 2023. "Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation" Diagnostics 13, no. 4: 696. https://doi.org/10.3390/diagnostics13040696

Yao, C.-C., Wang, J.-H., Chen, C.-H., Hung, C.-H., Yen, Y.-H., Kee, K.-M., Hu, T.-H., Tsai, M.-C., Kuo, Y.-H., & Lu, S.-N. (2023). Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Diagnostics, 13(4), 696. https://doi.org/10.3390/diagnostics13040696